Aminoglycoside antibiotics induce bacterial biofilm formation

Nature

Volumn 436, Issue 7054, 2005, Pages 1171-1175

  Hoffman, Lucas R ^a   D'Argenio, David A ^b   MacCoss, Michael J ^b   Zhang, Zhaoying ^c   Jones, Roger A ^c   Miller, Samuel I ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Universidad de Rutgers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; CELLS; DISEASES; ENZYMES; ESCHERICHIA COLI; PATIENT TREATMENT;

ABIOTIC SURFACES; CHRONIC INFECTIONS; CYSTIC FIBROSIS; P. AERUGINOSA CELLS;

BIOFILMS;

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; GUANOSINE TRIPHOSPHATE; PHOSPHODIESTERASE; TOBRAMYCIN;

ANTIBIOTICS;

AMINOGLYCOSIDE RESPONSE REGULATOR GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BIOFILM; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVITY; ESCHERICHIA COLI; MUTANT; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REGULATORY MECHANISM; RESPIRATORY TRACT INFECTION; SECOND MESSENGER; SURFACE PROPERTY;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PROTEINS; BIOFILMS; CYCLIC GMP; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENES, BACTERIAL; GENETIC COMPLEMENTATION TEST; PHENOTYPE; PSEUDOMONAS AERUGINOSA; TOBRAMYCIN;

ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA;

EID: 24144466550     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03912     Document Type: Article

References (28)

1. Mah, T. F. et al. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426, 306-310 (2003).
2. Whiteley, M. et al. Gene expression in Pseudomonas aeruginosa biofilms. Nature 413, 860-864 (2001).
3. D'Argenio, D. A. & Miller, S. I. Cyclic di-GMP as a bacterial second messenger. Microbiol. 150, 2497-2502 (2004).
4. Ross, P. et al. The cyclic diguanylic acid regulatory system of cellulose synthesis in Acetobocter xylinum. Chemical synthesis and biological activity of cyclic nucleotide dimer, trimer, and phosphothioate derivatives. J. Biol. Chem. 265, 18933-18943 (1990).
5. Goh, E. B. et al. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc. Natl Acad. Sci. USA 99, 17025-17030 (2002).
6. Goodman, L. S. & Gilman, A. Goodman and Gilman's The Pharmacological Basis of Therapeutics (Macmillan, New York, 1985).
7. Barclay, M. L. et al. Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis. J. Antimicrob. Chemother. 37, 1155-1164 (1996).
8. Bergey, D. H. & Holt, J. G. Bergey's Manual of Systematic Bacteriology (Williams & Wilkins, Baltimore, 1984).
9. Mukhopadhyay, S. et al. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis. Respir. Med. 88, 203-211 (1994).
10. Ramsey, B. W. et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N. Engl. J. Med. 340, 23-30 (1999).
11. Chiang, P. & Burrows, L. L. Biofilm formation by hyperpiliated mutants of Pseudomonas aeruginosa. J. Bacteriol. 185, 2374-2378 (2003).
12. Rachid, S., Ohlsen, K., Witte, W., Hacker, J. & Ziebuhr, W. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob. Agents Chemother. 44, 3357-3363 (2000).
13. Bagge, N. et al. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrob. Agents Chemother. 48, 1175-1187 (2004).
14. Paul, R. et al. Cell cycle-dependent dynamic localization of a bacterial response regulator with a novel di-guanylate cyclase output domain. Genes Dev. 18, 715-727 (2004).
15. Simm, R., Morr, M., Kader, A., Nimtz, M. & Romling, U. GGDEF and EAL domains inversely regulate cyclic di-GMP levels and transition from sessility to motility. Mol. Microbiol. 53, 1123-1134 (2004).
16. Galperin, M. Y., Nikolskaya, A. N. & Koonin, E. V. Novel domains of the prokaryotic two-component signal transduction systems. FEMS Microbiol. Lett. 203, 11-21 (2001).
17. Jacobs, M. A. et al. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 100, 14339-14344 (2003).
18. Bobrov, A. G., Kirillina, O. & Perry, R. D. The phosphodiesterase activity of the HmsP EAL domain is required for negative regulation of biofilm formation in Yersinia pestis. FEMS Microbiol. Lett. 247, 123-130 (2005).
19. Huang, B., Whitchurch, C. B. & Mattick, J. S. FimX, a multidomain protein connecting environmental signals to twitching motility in Pseudomonas aeruginosa. J. Bacteriol. 185, 7068-7076 (2003).
20. O'Toole, G. A. & Kolter, R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30, 295-304 (1998).
21. Moskowitz, S. M., Foster, J. M., Emerson, J. & Burns, J. L. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J. Clin. Microbiol. 42, 1915-1922 (2004).
22. Drenkard, E. & Ausubel, F. M. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416, 740-743 (2002).
23. He, J. et al. The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes. Proc. Natl Acad. Sci. USA 101, 2530-2535 (2004).
24. Wolfgang, M. C. et al. Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 100, 8484-8489 (2003).
25. Bader, M. W. et al. Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol. Microbiol. 50, 219-230 (2003).
26. Rosenfeld, M. et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr. Pulmonol. 32, 356-366 (2001).
27. Hisert, K. M. et al. A glutamate-alanine-leucine (EAL) domain protein of Salmonella controls bacterial survival in mice, antioxidant defence and killing of macrophages: role of cyclic dIGMP. Mol. Microbiol. 56, 1234-1245 (2005).
28. Amikam, D, & Benziman, M. Cyclic diguanylic acid and cellulose synthesis in Agrobacterium tumefaciens. J. Bacteriol. 171, 6649-6655 (1989).